CoChat

Alpha-synuclein deregulates the expression of COL4A2 and impairs ER-Golgi function

Open access
Paiva, Isabel, Jain, Gaurav, Lázaro, Diana F., Jerčić, Kristina Gotovac, Hentrich, Thomas, Kerimoglu, Cemil, Pinho, Raquel, Szegő, Èva M., Burkhardt, Susanne, Capece, Vincenzo, Halder, Rashi, Islam, Rezaul, Xylaki, Mary, Caldi Gomes, Lucas A., Roser, Anna-Elisa, Lingor, Paul, Schulze-Hentrich, Julia M., Borovečki, Fran, Fischer, André, Outeiro, Tiago F. · 2018 · Neurobiology of Disease
Cited by 66

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Alpha-synuclein (aSyn) is the major protein component of Lewy bodies and Lewy neurites, the typical pathological hallmarks in Parkinson's disease (PD) and Dementia with Lewy bodies. aSyn is capable of inducing transcriptional deregulation, but the precise effect of specific aSyn mutants associated with familial forms of PD, remains unclear. Here, we used transgenic mice overexpressing human wild-type (WT) or A30P aSyn to compare the transcriptional profiles of the two animal models. We found that A30P aSyn promotes strong transcriptional deregulation and increases DNA binding. Interestingly, COL4A2, a major component of basement membranes, was found to be upregulated in both A30P aSyn transgenic mice and in dopaminergic neurons expressing A30P aSyn, suggesting a crucial role for collagen related genes in aSyn-induced toxicity. Finally, we observed that A30P aSyn alters Golgi morphology and increases the susceptibility to endoplasmic reticulum (ER) stress in dopaminergic cells. In total, our findings provide novel insight into the putative role of aSyn on transcription and on the molecular mechanisms involved, thereby opening novel avenues for future therapeutic interventions in PD and other synucleinopathies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2018.08.001

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 66

Metadata

Authors
Paiva, I., Jain, G., Lázaro, D. F., Jerčić, K. G., Hentrich, T., Kerimoglu, C., Pinho, R., Szegő, È. M., Burkhardt, S., Capece, V., Halder, R., Islam, R., Xylaki, M., Caldi Gomes, L. A., Roser, A.-E., Lingor, P., Schulze-Hentrich, J. M., Borovečki, F., Fischer, A., & Outeiro, T. F.
Venue
Neurobiology of Disease
Publisher
Elsevier BV
Published
2018-11
Volume
119
Pages
121-135
ISSN
0969-9961 (ISSN-L)
OpenAlex
W2886527336
Cited by
66
References
12
FWCI
3.56
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alpha-synuclein deregulates the expression of COL4A2 and impairs ER-Golgi function. https://app.cochat.ai/papers/10.1016/j.nbd.2018.08.001
The paper
Paiva, I., Jain, G., Lázaro, D. F., Jerčić, K. G., Hentrich, T., Kerimoglu, C., Pinho, R., Szegő, È. M., Burkhardt, S., Capece, V., Halder, R., Islam, R., Xylaki, M., Caldi Gomes, L. A., Roser, A.-E., Lingor, P., Schulze-Hentrich, J. M., Borovečki, F., Fischer, A., & Outeiro, T. F. (2018). Alpha-synuclein deregulates the expression of COL4A2 and impairs ER-Golgi function. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2018.08.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.